Search

Since 2010 there has been an exponential increase of the number of transplants performed from related donors. The development of haploidentical transplants increases the resort to related-donation, which presents two main advantages: a less important financial cost and a faster availability of the graft. Standards for mandatory accreditation exist, but the adherence to these recommendations is not optimal: currently, different practices regarding the organizational modalities of care, recruitment criteria, qualification and follow-up of related donors have been observed among French transplant centers. The Francophone Society of Marrow Transplant and Cellular Therapy (SFGM-TC) has developed guidelines for the consent and the non-eligibility criteria for hematopoietic stem cell donors. A multidisciplinary group has devised a booklet as a medium to inform donors about hematopoietic cell donation and transplantation in a clear and accessible language. This paper provides recommendations on post-donation follow-up, taking into account both medical standards and organizational constraints of French centers. Some tools are proposed.

The development of haplo-identical transplants brings to an increased resort to related donation: from 2005 till 2015, this resort increased by 291 %. Beyond the less important financial costs, the related donation also presents the advantage of a faster availability of the donor, avoiding risk of relapse before the procedure.In spite of the existing recommendations, we notice a diversity of the practices among French centers as for the organizational modalities of care, for recruitment criteria, qualification and follow-up of related donors.French Society of Marrow Transplant and Cellular Therapy proposed recommendations concerning the consent and non-qualification criteria of related donors. A multidisciplinary group to facilitate the information about Hematopoietic stem cells donation and transplantation conceived a notebook.In the present article, we propose recommendations for post-donation follow-up, taking into account at the same time medical imperatives and organizational constraints of transplantation teams. Some tools are also presented., Le développement des greffes haplo-identiques amène à un recours de plus en plus important aux donneurs apparentés : de 2005 à 2015, ce recours s’est accru de 291%. Au-delà des coûts financiers moins importants, le don intrafamilial présente également l’avantage d’une disponibilité plus rapide du donneur, évitant ainsi des risques de rechute avant la procédure.En dépit des recommandations existantes, on constate une diversité des pratiques dans les différents centres français quant aux modalités organisationnelles de prise en charge, aux critères de recrutement, qualification et suivi des donneurs apparentés. La Société Française de Greffe de Moelle et Thérapie Cellulaire a fait des propositions concernant le consentement et les critères de non-qualification des donneurs apparentés de cellules souches hématopoïétiques. Un livret a été conçu par un groupe multidisciplinaire afin de faciliter l’information sur le don et sur l’allogreffe. Dans le présent article, prenant en compte à la fois les impératifs médicaux de surveillance et les contraintes organisationnelles des centres greffeurs, nous proposons des recommandations pour le suivi des donneurs apparentés. Quelques outils (documents d’information, questionnaires) sont présentés.